257 related articles for article (PubMed ID: 5735705)
1. [Behavior of certain biologic parameters of hepatic and renal function during therapy with rifomycin B diethylamide (rifamide) administered by venous infusion].
Boccitto G; Sbampato M; Sternini N
Ann Ist Carlo Forlanini; 1968; 28(2):126-41. PubMed ID: 5735705
[No Abstract] [Full Text] [Related]
2. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
Zanotelli F; Perusi O
G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
[No Abstract] [Full Text] [Related]
3. [Results of treatment of chronic destructive pulmonary tuberculosis with reserve tuberculostatic preparations including some new preparations].
Rabukhin AE; Alekseeva VM; Ivanova ES; Kubyshkina VF; Kliuchareva EA
Probl Tuberk; 1970; 48(8):18-22. PubMed ID: 5496733
[No Abstract] [Full Text] [Related]
4. [Treatment of chronic tuberculosis with ethambutol and prothionamide associated with rifomycin of capreomycin].
Grassi C
Acta Tuberc Pneumol Belg; 1969; 60(3):450-4. PubMed ID: 4906991
[No Abstract] [Full Text] [Related]
5. [Duration of the after-control of the tuberculous patients following the termination of the treatment].
Neumann G
Wien Med Wochenschr; 1972 Dec; 122(51):764-8. PubMed ID: 4346497
[No Abstract] [Full Text] [Related]
6. [Experience with te new antitubercular agents isoxyl, ethambutol, morphazinamid and rifomycin].
Daddi G
Wien Med Wochenschr; 1967 Mar; 117(11):266-8. PubMed ID: 5626324
[No Abstract] [Full Text] [Related]
7. [The role of rifampicin in the treatment of recent tubercular processes].
Catena E; Del Bono M; Marsico SA
Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):329-52. PubMed ID: 5307454
[No Abstract] [Full Text] [Related]
8. [Combined antitubercular treatment of pulmonary tuberculosis in adults].
Böszörményi M
Orv Hetil; 1970 Mar; 111(11):603-8. PubMed ID: 4911914
[No Abstract] [Full Text] [Related]
9. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
Freerksen E
Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
[No Abstract] [Full Text] [Related]
10. [Intravenous morphazinamide. Tolerance of the drug and therapeutic effects].
Celotti A
Minerva Med; 1965 Sep; 56(71):2892-7. PubMed ID: 5322270
[No Abstract] [Full Text] [Related]
11. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
Sirota DS; Man'kovetskiĭ EF; Koĭfman SG; Vatsyk MZ
Probl Tuberk; 1974; (10):17-9. PubMed ID: 4370967
[No Abstract] [Full Text] [Related]
12. [Advances in the therapy of tuberculosis].
Corbalán Trumbull G
Rev Med Chil; 1970 Jan; 98(1):26-30. PubMed ID: 4157372
[No Abstract] [Full Text] [Related]
13. [Current status of the antitubercular chemotherapy].
Radenbach KL
Internist (Berl); 1973 Mar; 14(3):100-10. PubMed ID: 4573242
[No Abstract] [Full Text] [Related]
14. Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin.
Radenbach KL
Scand J Respir Dis Suppl; 1969; 69():43-53. PubMed ID: 4906373
[No Abstract] [Full Text] [Related]
15. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
[No Abstract] [Full Text] [Related]
16. [New drugs in antitubercular therapy].
Favez G
Helv Med Acta Suppl; 1969; 49():66-80. PubMed ID: 4912509
[No Abstract] [Full Text] [Related]
17. Drugs in the treatment of tuberculosis--1969.
Beacham EG
Johns Hopkins Med J; 1969 Nov; 125(5):286-90. PubMed ID: 5366128
[No Abstract] [Full Text] [Related]
18. [Clinical tolerance of rifampycin administered alone or in combination with other antitubercular drugs].
Carratù L; Sonaglioni F; Natali P
Arch Tisiol Mal Appar Respir; 1968 May; 23(5):399-410. PubMed ID: 5306592
[No Abstract] [Full Text] [Related]
19. [Rifampicin, ethambutol and drugs of the 2d series in chemotherapy of chronic cavernous tuberculosis of the lungs].
Mamolat AS; Bialik IB
Probl Tuberk; 1979 Nov; (11):20-6. PubMed ID: 530963
[No Abstract] [Full Text] [Related]
20. [Comparative characteristics of the use of rifadin and ethambutol in the complex treatment of patients with fibro-cavernous pulmonary tuberculosis].
Tarasova EF; Sagalovich VIa
Probl Tuberk; 1974; (12):26-30. PubMed ID: 4445131
[No Abstract] [Full Text] [Related]
[Next] [New Search]
